A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
Clinical trial NCT04548648 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04548648
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2025-05-14
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.